User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 15 results.
    • Journal article
    Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial.
    Mounier, Nicolas Heutte, Natacha Thieblemont, Catherine Briere, Josette Gaulard, Philippe Feugier, Pierre Ghesquieres, Hervé Van Den Neste, Eric Robu, Daniela Tilly, Herve Bouabdallah, Reda Safar, Violaine Coiffier, Bertrand (2012) Clinical Lymphoma, Myeloma & Leukemia — Vol. 12, no. 3, p. 151-154 (2012)
    • Speech
    Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte
    Ghesquieres, Herve Van Den Neste, Eric[UCL] Ferlay, Celine Bajard, Agathe Sebban, Catherine Perol, David Bosly, André[UCL] Casasnovas, Olivier Reman, Oumedaly Coiffier, Bertrand Tilly, Herve Morel, Pierre De Prijck, Bernard Colin, Philippe Ketterer, Nicolas Antoine, Thyss Delannoy, Andre Haioun, Corinne Devidas, Alain Biron, Pierre Blay, Jean-Yves (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans (La)
    • Speech
    R-CHOP14 Compared to R-CHOP21 in Elderly Patients with Diffuse Large B-Cell Lymphoma: Results of the Interim Analysis of the LNH03-6B GELA Study
    Delarue, Richard Tilly, Herve Salles, Gilles Gisselbrecht, Christian Mounier, Nicolas Fournier, Marion Molina, Thierry Jo Bonmati, Caroline Ghesquieres, Herve Blanc, Michel Germain, Delphine Girard, Laurence Haioun, Corinne Bosly, André[UCL] (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans(La)
    • Journal article
    Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol
    Morel, Pierre Munck, Jean-Nicolas Coiffier, Bertrand Gisselbrecht, Christian Ranta, Dana Bosly, André[UCL] Tilly, Herve Quesnel, Bruno Thyss, Antoine Mounier, Nicolas Briere, Josette Molina, Thierry Reyes, Felix (2010) Leukemia and Lymphoma — Vol. 51, no. 9, p. 1668-77 (2010)
    • Speech
    10 Years Follow-up of the GELA LNH98.5 Study, First Randomized Study Comparing R-CHOP to CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma
    Coiffier, Bertrand Van Den Neste, Eric[UCL] Gisselbrecht, Christian Bosly, André[UCL] Herbrecht, Raoul Bouabdallah, Reda Morel, Pierre Bordessoule, Dominique Haioun, Corinne Tilly, Herve Salles, Gilles (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans (La)
    • Journal article
    Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P mutated diffuse large B-cell lymphoma: analysis of 361 cases.
    Dubois, Sydney Viailly, Pierre-Julien Bohers, Elodie Bertrand, Philippe Ruminy, Philippe Marchand, Vinciane Maingonnat, Catherine Mareschal, Sylvain Picquenot, Jean-Michel Penther, Dominique Jais, Jean-Philippe Tesson, Bruno Peyrouze, Pauline Figeac, Martin Desmots, Fabienne Fest, Thierry Haioun, Corinne Lamy, Thierry Copie-Bergman, Christiane Fabiani, Bettina Delarue, Richard Peyrade, Frederic André, Marc[UCL] Ketterer, Nicolas Leroy, Karen Salles, Gilles Molina, Thierry J Tilly, Herve Jardin, Fabrice (2017) Clinical Cancer Research — Vol. 23, no. 9, p. 2232-2244 (2017)
    • Journal article
    Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA.
    Le Gouill, Steven Ghesquieres, Herve Obéric, Lucie Morschhauser, Franck Tilly, Herve Ribrag, Vincent Lamy, Thierry Thieblemont, Catherine Maisonneuve, Herve Gerard Gressin, Remy Bouabdallah, Krimo Haioun, Corinne Damaj, Gandhi Fornecker, Luc-Matthieu Bouabdallah, Reda Feugier, Pierre Sibon, David Cartron, Guillaume Bonnet, Christophe André, Marc[UCL] Chartier, Loic Ruminy, Philippe Kraeber-Bodere, F Bodet-Milin, C Berriolo-Riedinger, Alina Briere, Josette Jais, Jean-Philippe Molina, Thierry Itti, Emmanuel Casasnovas, Olivier (2021) Blood — Vol. 137, no. 17, p. 2307-2320 (2021)
    • Speech
    90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study
    Gisselbrecht, Christian Decaudin, Didier Mounier, Nicolas Tilly, Herve Ribrag, Vincent Sebban, Catherine Milpied, Noel Morschhauser, Franck Coiffier, Bertrand Le Gouill, Steven Lederlin, Pierre Delarue, Richard Laurent, Guy Bosly, André[UCL] (2007) 49th Annual Meeting of the American-Society-of-Hematology — Atlanta(Ga)
    • Journal article
    Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT
    Drozd-Sokołowska, Joanna Gras, Luuk Zinger, Nienke Snowden, John A. Arat, Mutlu Basak, Grzegorz Pouli, Anastasia Crawley, Charles Wilson, Keith M. O. Tilly, Herve Byrne, Jennifer Bulabois, Claude Eric Passweg, Jakob Ozkurt, Zubeyde Nur Schroyens, Wilfried Lioure, Bruno Colorado Araujo, Mercedes Poire, Xavier[UCL] Van Gorkom, Gwendolyn Gurman, Gunhan de Wreede, Liesbeth C. Hayden, Patrick J. Beksac, Meral Schönland, Stefan O. Yakoub-Agha, Ibrahim (2022) Bone Marrow Transplantation — Vol. 57, no. 4, p. 633-640 (2022)
    • Journal article
    FDG-PET driven consolidation strategy in diffuse large B-cell lymphoma: Final results of a randomized phase II study.
    Casasnovas, Rene-Olivier Ysebaert, Loic Thieblemont, Catherine Bachy, Emmanuel Feugier, Pierre Delmer, Alain Tricot, Sabine Gabarre, Jean André, Marc[UCL] Fruchart, Christophe Mounier, Nicolas Delarue, Richard Meignan, Michel Berriolo-Riedinger, Alina Bardet, Stephane Emile, Jean-Francois Jais, Jean-Philippe Haioun, Corinne Tilly, Herve Morschhauser, Franck (2017) Blood — Vol. 130, no. 11, p. 1315-1326 (2017)
    • Journal article
    Outcomes of elderly diffuse large B-cell lymphoma patients treated with R-CHOP: 10-year follow-up of the LNH03-6B trial.
    Camus, Vincent Belot, Aurelien Obéric, Lucie Sibon, David Ghesquieres, Herve Thieblemont, Catherine Fruchart, Christophe Casasnovas, Olivier Michot, Jean-Marie Molina, Thierry Bosly, André[UCL] Joubert, Clémentine Haioun, Corinne Nicolas-Virelizier, Emmanuelle Feugier, Pierre Fitoussi, Olivier Delarue, Richard Tilly, Herve (2022) Blood advances — Vol. 6, no. 24, p. 6169-6179 (2022)
    • Journal article
    Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
    Sebban, Catherine Mounier, Nicolas Brousse, Nicole Belanger, Coralie Brice, Pauline Haioun, Corinne Tilly, Herve Feugier, Pierre Bouabdallah, Reclah Doyen, Chantal[UCL] Salles, Gilles Coiffier, Bertrand (2006) Blood — Vol. 108, no. 8, p. 2540-4 (2006)
    • Journal article
    Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
    Coiffier, Bertrand Van Den Neste, Eric[UCL] Thieblemont, Catherine Lepeu, Gerard Plantier, Isabelle Castaigne, Sylvie Lefort, Sophie Marit, Gerald Macro, Margaret Sebban, Catherine Belhadj, Karim Bordessoule, Dominique Ferme, Christophe Tilly, Herve (2010) Blood — Vol. 116, no. 12, p. 2040-5 (2010)
    • Speech
    Characteristics of Refractory and Relapsing Patients with Diffuse Large B-Cell Lymphoma.
    Coiffier, Bertrand Salles, Gilles Bosly, André[UCL] Gaulard, Philippe Haioun, Corinne Casasnovas, Olivier Mounier, Nicolas Delfau, Marie Helene Sebban, Catherine Feugier, Pierre Recher, Christian Delarue, Richard Ketterer, Nicolas Tilly, Herve Gisselbrecht, Christian (2008) 50th Annual Meeting of the American-Society-of-Hematology — San Francisco(Ca)
    • Speech
    Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study.
    Delarue, Richard Haioun, Corinne Broussais-Guillaumot, Florence Sibon, David Fournier, Marion Mounier, Nicolas Petrella, Tony Bologna, Serge Fruchart, Christophe Ferme, Christophe Recher, Christian Picard, Stephanie Tilly, Herve Bosly, André[UCL] (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans(La)